Top 4 NASDAQ Stocks In The Drugs Generic Industry With The Highest EPS Growth Forecast For Next 5 Years

Below are the top drugs generic stocks on the NASDAQ in terms of EPS growth forecast for the next five years.

Sagent Pharmaceuticals, Inc.SGNT

earnings per share growth forecast for the next five years is 70.00%. Sagent Pharmaceuticals' PEG ratio is 0.88.

Evoke Pharma, Inc.EVOK

EPS growth forecast for the next five years is 40.00%. Evoke Pharma's trailing-twelve-month EPS is -$1.98.

Akorn, Inc.AKRX

EPS growth forecast for the next five years is 33.15%. Akorn's trailing-twelve-month profit margin is 5.10%.

Avanir Pharmaceuticals, Inc.AVNR

earnings per share growth forecast for the next five years is 19.20%. Avanir Pharmaceuticals' trailing-twelve-month revenue is $115 million.

Momentum31.55

Growth44.33

QualityN/A

Value89.96

Short

Medium

Long